Cationic Amphiphilic Polyproline Helices: Side-Chain Variations and Cell-Specific Internalization

被引:37
作者
Geisler, Iris [1 ]
Chmielewski, Jean [1 ]
机构
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
关键词
amphiphilic; cell penetrating peptides; cell specificity; polyproline; PPII helix; ANTIMICROBIAL PEPTIDES; PENETRATING PEPTIDES; TAT PEPTIDE; ANTENNAPEDIA HOMEODOMAIN; 3RD HELIX; DELIVERY; AGENTS; TRANSDUCTION; MECHANISM; PROTEINS;
D O I
10.1111/j.1747-0285.2008.00759.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell-penetrating peptides present an attractive and efficient tool for the delivery of a variety of cell impermeable cargoes across the cellular membrane. Cell-penetrating peptides usually consist of short basic peptide sequences that are internalized by a variety of cell lines. Most cell-penetrating peptides lack cell specificity, however, which greatly limits their use as efficient therapeutic agents. Herein, we present two cell-penetrating peptides displaying a type II polyproline helical backbone that are functionalized to contain six cationic moieties and two distinctive hydrophobic functionalities, namely isobutyl or benzyl groups. The uptake efficiency of these cationic amphiphilic polyproline helices was studied in seven different cell lines, six cancerous (MCF-7, HOS, HT1080, HeLa, KB-FD, KB3-1) and one non-cancerous (WI 38). The cationic amphiphilic polyproline helix P11LRR at 50 mu m showed high specificity toward MCF-7 breast cancer cells. Co-culture experiments with P11LRR demonstrated almost exclusive internalization by MCF-7 cells and not WI38. The replacement of the isobutyl hydrophobic group with a benzyl moiety resulted in a shift in uptake efficiency and specificity across some cell lines. These results demonstrate that the type of hydrophobic residues utilized in the creation of cell-penetrating peptides can strongly influence the extent and specificity of cellular internalization.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 34 条
[31]   Cell-penetrating peptides as delivery vehicles for biology and medicine [J].
Stewart, Kelly M. ;
Horton, Kristin L. ;
Kelley, Shana O. .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2008, 6 (13) :2242-2255
[32]   Present and future of cell-penetrating peptide mediated delivery systems: "Is the Trojan horse too wild to go only to Troy?" [J].
Vives, E .
JOURNAL OF CONTROLLED RELEASE, 2005, 109 (1-3) :77-85
[33]   Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer [J].
Wadia, JS ;
Dowdy, SF .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) :579-596
[34]   Intracellular cargo delivery using tat peptide and derivatives [J].
Zhao, M ;
Weissleder, R .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) :1-12